The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study

To determine whether the bihormonal bionic pancreas (BHBP) improves glycemic control and reduces hypoglycemia in individuals with congenital hyperinsulinism (HI) and postpancreatectomy diabetes (PPD) compared with usual care (UC). Ten subjects with HI and PPD completed this open-label, crossover pil...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 44; no. 11; pp. 2582 - 2585
Main Authors Rayannavar, Arpana, Mitteer, Lauren M., Balliro, Courtney A., El-Khatib, Firas H., Lord, Katherine L., Hawkes, Colin P., Ballester, Lance S., Damiano, Edward R., Russell, Steven J., De León, Diva D.
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.11.2021
Subjects
Online AccessGet full text
ISSN0149-5992
1935-5548
1935-5548
DOI10.2337/dc21-0416

Cover

More Information
Summary:To determine whether the bihormonal bionic pancreas (BHBP) improves glycemic control and reduces hypoglycemia in individuals with congenital hyperinsulinism (HI) and postpancreatectomy diabetes (PPD) compared with usual care (UC). Ten subjects with HI and PPD completed this open-label, crossover pilot study. Coprimary outcomes were mean glucose concentration and time with continuous glucose monitoring (CGM) glucose concentration <3.3 mmol/L. Mean (SD) CGM glucose concentration was 8.3 (0.7) mmol/L in the BHBP period versus 9 (1.8) mmol/L in the UC period ( = 0.13). Mean (SD) time with CGM glucose concentration <3.3 mmol/L was 0% (0.002) in the BHBP period vs. 1.3% (0.018) in the UC period ( = 0.11). Relative to UC, the BHBP resulted in comparable glycemic control in our population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
ISSN:0149-5992
1935-5548
1935-5548
DOI:10.2337/dc21-0416